| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 10.52B | 10.51B | 10.43B | 10.71B | 9.51B | 7.87B |
| Gross Profit | 2.90B | 2.83B | 2.68B | 2.66B | 2.06B | 1.30B |
| EBITDA | 1.48B | 1.49B | 1.77B | 1.98B | 1.46B | 673.77M |
| Net Income | 593.78M | 709.01M | 962.25M | 1.17B | 630.03M | -161.52M |
Balance Sheet | ||||||
| Total Assets | 12.00B | 12.01B | 12.42B | 13.40B | 12.73B | 13.26B |
| Cash, Cash Equivalents and Short-Term Investments | 3.17B | 3.34B | 3.58B | 4.04B | 3.22B | 3.10B |
| Total Debt | 1.26B | 1.51B | 2.46B | 4.30B | 5.13B | 5.97B |
| Total Liabilities | 4.54B | 4.44B | 5.41B | 7.49B | 8.05B | 9.31B |
| Stockholders Equity | 7.46B | 7.58B | 7.00B | 5.92B | 4.68B | 3.95B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 976.40M | 1.43B | 1.47B | 985.55M | 239.85M |
| Operating Cash Flow | 0.00 | 1.20B | 1.59B | 1.71B | 1.22B | 558.79M |
| Investing Cash Flow | 0.00 | -216.35M | -163.00M | -204.10M | -161.04M | -186.64M |
| Financing Cash Flow | 0.00 | -1.15B | -2.11B | -874.50M | -1.06B | 1.21B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥319.68B | 8.42 | ― | 2.04% | -0.69% | -29.88% | |
77 Outperform | ¥322.97B | 17.58 | ― | 1.49% | 18.20% | 28.13% | |
75 Outperform | ¥436.13B | 28.58 | 7.44% | 1.76% | -0.89% | 53.87% | |
75 Outperform | ¥73.49B | 12.98 | ― | 3.12% | 2.78% | -5.32% | |
62 Neutral | ¥8.63B | 65.95 | ― | 1.78% | -1.17% | -42.36% | |
62 Neutral | ¥471.36B | 19.19 | 5.63% | 2.35% | -9.06% | -35.95% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |